Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians

Thibaut Petroni1, Azfar Zaman2, Jean-Louis Georges3

  • 1Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France.

Insights

Primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is feasible in nonagenarians. This approach shows good reperfusion rates and 53% survival at one year, suggesting it can be offered to selected elderly patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • ST-segment elevation myocardial infarction (STEMI) in nonagenarians presents unique challenges.
  • Outcomes of primary percutaneous coronary intervention (PCI) in this extreme age group are not well-established.

Purpose of the Study:

  • To assess the feasibility and outcomes of primary PCI for STEMI in patients aged 90 years and older.
  • To evaluate short-term and long-term survival rates following primary PCI in this cohort.

Main Methods:

  • A multicentre retrospective study included 145 consecutive nonagenarian patients treated with primary PCI for STEMI.
  • Data on demographics, clinical presentation, procedural details, and clinical events were collected.
  • Mortality and severe clinical events were assessed at 6 months and 1 year post-procedure.

Main Results:

  • Primary PCI was successfully achieved in 86% of cases, with a transradial approach used in 60%.
  • In-hospital mortality was 24%, with 6-month and 1-year survival rates of 61% and 53%, respectively.
  • Major bleeding occurred in 4% of patients, and median ejection fraction post-PCI was 41.5%.

Conclusions:

  • Primary PCI is a feasible and effective treatment for STEMI in nonagenarians.
  • The transradial approach is well-tolerated in this population.
  • Selected nonagenarian patients with STEMI may benefit from primary PCI, offering a survival rate of 53% at one year.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
503
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
405
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
309
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373